Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Jeanette M. BjorkquistPFO and PAO | Assembly BiosciencesASMB | Open-market sale | 06/17 | 06/18 | 29 sh | $23.25 | $674.25 | −0.2% |
Assembly BiosciencesASMB | Open-market sale | 03/30 | 03/31 | 328 sh2 trades | $26.69avg. | $8,754.64 | −2.9% | |
Assembly BiosciencesASMB | Open-market sale | 03/30 | 03/31 | 197 sh2 trades | $26.69avg. | $5,257.61 | −0.5% | |
Gilead Sciences10% Owner | Assembly BiosciencesASMB | Open-market buy | 25/08/08 | 25/10/03 | 2,295,920 sh | In footnote | No stated value | +103.9% |
John G. McHutchisonDirector | Assembly BiosciencesASMB | Open-market sale | 25/03/31 | 25/04/15 | 757 sh | $9.85 | $7,456.45 | −4.0% |
Jason A. OkazakiCEO and President | Assembly BiosciencesASMB | Open-market sale | 25/03/31 | 25/04/01 | 355 sh | $9.85 | $3,496.75 | −2.3% |
Jeanette M. BjorkquistPrincipal Accounting Officer | Assembly BiosciencesASMB | Open-market sale | 25/03/31 | 25/04/01 | 180 sh | $9.85 | $1,773 | −3.8% |
Nicole S. WhiteChief Manufacturing Officer | Assembly BiosciencesASMB | Open-market sale | 25/03/31 | 25/04/01 | 197 sh | $9.85 | $1,940.45 | −1.7% |
Michael HoughtonDirector | Assembly BiosciencesASMB | Open-market buy | 24/12/30 | 24/12/31 | 3,202 sh | $15.61 | $49,983.22 | No record |
Gilead Sciences10% Owner | Assembly BiosciencesASMB | Open-market buy | 24/12/19 | 24/12/23 | 940,499 sh | $21.37 | $20,098,463.63 | +74.1% |
Assembly BiosciencesASMB | Open-market buy | 24/11/22–24/11/25 | 24/11/26 | 25,000 sh3 trades | $14.88avg. | $372,036.88 | +3.6% | |
Nicole S. WhiteChief Manufacturing Officer | Assembly BiosciencesASMB | Open-market sale | 24/11/18 | 24/11/19 | 40 sh | $16.29 | $651.6 | −0.3% |
Alexander Schornstein10% Owner | Assembly BiosciencesASMB | Open-market buy | 24/10/08 | 24/10/09 | 10,000 sh | $14.58 | $145,800 | +1.4% |
Jason A. OkazakiCEO and President | Assembly BiosciencesASMB | Open-market sale | 24/10/03 | 24/10/04 | 197 sh | $14.81 | $2,917.57 | −1.3% |
Nicole S. WhiteChief Manufacturing Officer | Assembly BiosciencesASMB | Open-market sale | 24/10/03 | 24/10/04 | 157 sh | $14.81 | $2,325.17 | −1.3% |
Jason A. OkazakiCEO and President | Assembly BiosciencesASMB | Open-market sale | 24/08/02 | 24/08/05 | 981 sh | $14.23 | $13,959.63 | −6.1% |
Nicole S. WhiteChief Manufacturing Officer | Assembly BiosciencesASMB | Open-market sale | 24/08/02 | 24/08/05 | 785 sh | $14.23 | $11,170.55 | −6.1% |
Assembly BiosciencesASMB | Open-market buy | 24/07/03–24/07/05 | 24/07/08 | 9,000 sh2 trades | $12.40avg. | $111,630.74 | +1.3% | |
Gilead Sciences10% Owner | Assembly BiosciencesASMB | Open-market buy | 24/06/17 | 24/06/20 | 179,500 sh | In footnote | No stated value | +16.5% |
John G. McHutchisonDirector | Assembly BiosciencesASMB | Open-market sale | 24/05/23 | 24/05/24 | 2,117 sh | $14.93 | $31,606.81 | −10.0% |
